減損損失 - 医薬品、支払手形、負債の部合計他1件
- 【期間】
| 年度 | 減損損失 - 医薬品 | 支払手形 | 負債の部合計 | 外部顧客への売上高 - 基礎化学 |
|---|
| 2008/03 | - | | 58.9億 | | 1.35兆 | | - | |
| 2009/03 | - | | 39.1億 | -33.6% | 1.25兆 | -7.8% | - | |
| 2010/03 | - | | 44.3億 | +13.4% | 1.56兆 | +25.3% | - | |
| 2011/03 | - | | 37.8億 | -14.6% | 1.61兆 | +2.9% | - | |
| 2012/03 | - | | 37.1億 | -2% | 1.62兆 | +0.5% | - | |
| 2013/03 | 4.3億 | | 29.5億 | -20.4% | 1.72兆 | +6.7% | 2635億 | |
| 2014/03 | 70.9億 | 大幅増 | 39億 | +32.3% | 1.85兆 | +7.5% | 2869億 | +8.9% |
| 2015/03 | 53.1億 | -25.1% | 32.3億 | -17.2% | 1.76兆 | -5% | 3120億 | +8.7% |
| 2016/03 | 5.53億 | -89.6% | 34.5億 | +6.7% | 1.57兆 | -10.8% | - | |
| 2017/03 | - | | 35.9億 | +4% | 1.7兆 | +8.2% | - | |
| 2018/03 | - | | 35.5億 | -1.1% | 1.14兆 | -32.8% | - | |
| 2019/03 | - | | 29.8億 | -16.1% | 1.15兆 | +0.3% | - | |
| 2020/03 | - | | 32.2億 | +8.1% | 1.26兆 | +10.1% | - | |
| 2021/03 | - | | 25.7億 | -20% | 1.38兆 | +9.7% | - | |
| 2022/03 | - | | 17.1億 | -33.4% | 1.37兆 | -0.9% | - | |
| 2023/03 | - | | 30.2億 | +76% | 1.39兆 | +1.7% | - | |
| 2024/03 | - | | - | | - | | - | |
